Golumbeski George

Golumbeski George is listed in filings as Director at Acumen Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including 12 public disclosures. Recent filings connect the profile to Acumen Pharmaceuticals, Inc. (ABOS), Shattuck Labs, Inc. (STTK), and Sage Therapeutics, Inc. (SAGE). The current snapshot covers public activity from Jun 11, 2024 to Jun 5, 2026. Reported amounts are shown as $121.9K to $95.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.